Venmax Drugs and Pharmaceuticals Ltd — Board Meeting, 23-07-2025: Board Meeting

Venmax Drugs & Pharmaceuticals has released its financial results for the quarter just ended. The company reported revenue from operations of Rs 1.21 crore. For this period, the profit stood at Rs 0.0374 crore. Earnings per share were Rs 0.071. The financial statements were reviewed by the Audit Committee and approved by the Board of Directors, with statutory auditors providing an unmodified limited review conclusion. This update provides investors with key insights into the company's recent operational performance and financial health.